US approves 1st drug developed to prevent chronic migraines
TRENTON, N.J. (AP) — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines.
The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for sale. It's the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills for preventing migraines are being tested.
Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don't help much... read more
- 11:57 Sutherland Springs survivor urges gun owners to push back against NRA
- 11:18 The Latest: US team heading to Singapore to work on summit
- 10:19 Family grateful for Utah man's 'miracle' Venezuela release
- 09:36 Resistance makes subtle impact even where Trump is popular
- 02:03 Giuliani says White House wants briefing on classified info
- 01:02 Trump stays out of messy House immigration fight
- 00:46 Trump shifts stance on Korea summit from 'off' to 'maybe'
- 00:46 Trump's dizzying shifts on issues from NK, guns, health care